National Brain Tumor Society
North America, Massachusetts, United States, Newton
Description
National brain tumor society discovers cure, deliver effective treatments, and advocate for patients and care partners.
Investor Profile
National Brain Tumor Society has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Medical, Therapeutics.
Stage Focus
- Seed (67%)
- Series A (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
- Health Care
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
